Terms: = Colorectal cancer AND PML, TRIM19, 5371, ENSG00000140464, MYL, PP8675, RNF71 AND Treatment
10 results:
1. Vitamin C enhances co-localization of novel TET1 nuclear bodies with both Cajal and pml bodies in colorectal cancer cells.
El Osmani N; Prévostel C; Picque Lasorsa L; El Harakeh M; Radwan Z; Mawlawi H; El Sabban M; Shirinian M; Dassouki Z
Epigenetics; 2024 Dec; 19(1):2337142. PubMed ID: 38583183
[TBL] [Abstract] [Full Text] [Related]
2. Receipt of Targeted Therapy and Survival Outcomes in Patients With Metastatic colorectal cancer.
Koroukian SM; Booker BD; Vu L; Schumacher FR; Rose J; Cooper GS; Selfridge JE; Markt SC
JAMA Netw Open; 2023 Jan; 6(1):e2250030. PubMed ID: 36656585
[TBL] [Abstract] [Full Text] [Related]
3. Analytical similarity assessment of myl-1402O to reference Bevacizumab.
Goyal P; Vats B; Subbarao M; Honnappa CG; Kabadi P; Rohil S; Bera A; Mehta GR; Pai H; Adhikari L; Tagore R; Sharma S; Venkatachala R; Nair P; Annegowda S; Sahu A; Trivedi S; Shastri N; Gokhale Y; Thomas R; Thakur A; Mohan D; Rao K U; Melarkode R; Ullanat R
Expert Opin Biol Ther; 2022 Feb; 22(2):271-298. PubMed ID: 34465264
[TBL] [Abstract] [Full Text] [Related]
4. Impact of the COVID-19 pandemic on the detection and management of colorectal cancer in England: a population-based study.
Morris EJA; Goldacre R; Spata E; Mafham M; Finan PJ; Shelton J; Richards M; Spencer K; Emberson J; Hollings S; Curnow P; Gair D; Sebag-Montefiore D; Cunningham C; Rutter MD; Nicholson BD; Rashbass J; Landray M; Collins R; Casadei B; Baigent C
Lancet Gastroenterol Hepatol; 2021 Mar; 6(3):199-208. PubMed ID: 33453763
[TBL] [Abstract] [Full Text] [Related]
5. Assessment of Duration and Effects of 3 vs 6 Months of Adjuvant Chemotherapy in High-Risk Stage II colorectal cancer: A Subgroup Analysis of the TOSCA Randomized Clinical Trial.
Petrelli F; Labianca R; Zaniboni A; Lonardi S; Galli F; Rulli E; Rosati G; Corallo S; Ronzoni M; Cardellino GG; Mattioli R; Mambrini A; Ciuffreda L; Banzi M; Pusceddu V; Maiello E; Zampino M; Zagonel V; Marchetti P; Corsi D; Rimassa L; Cinieri S; Sobrero A
JAMA Oncol; 2020 Apr; 6(4):547-551. PubMed ID: 32053133
[TBL] [Abstract] [Full Text] [Related]
6. Multitargeting activity of miR-24 inhibits long-term melatonin anticancer effects.
Mori F; Ferraiuolo M; Santoro R; Sacconi A; Goeman F; Pallocca M; Pulito C; Korita E; Fanciulli M; Muti P; Blandino G; Strano S
Oncotarget; 2016 Apr; 7(15):20532-48. PubMed ID: 26967561
[TBL] [Abstract] [Full Text] [Related]
7. Personalized medicine and pharmacogenetic biomarkers: progress in molecular oncology testing.
Ong FS; Das K; Wang J; Vakil H; Kuo JZ; Blackwell WL; Lim SW; Goodarzi MO; Bernstein KE; Rotter JI; Grody WW
Expert Rev Mol Diagn; 2012 Jul; 12(6):593-602. PubMed ID: 22845480
[TBL] [Abstract] [Full Text] [Related]
8. Human polyomavirus JC reactivation and pathogenetic mechanisms of progressive multifocal leukoencephalopathy and cancer in the era of monoclonal antibody therapies.
Bellizzi A; Nardis C; Anzivino E; Rodìo D; Fioriti D; Mischitelli M; Chiarini F; Pietropaolo V
J Neurovirol; 2012 Feb; 18(1):1-11. PubMed ID: 22290500
[TBL] [Abstract] [Full Text] [Related]
9. No evidence for pml-RARa bcr1 fusion gene in colorectal cancer.
Herreros-Villanueva M
Mol Biol Rep; 2012 May; 39(5):5387-91. PubMed ID: 22167334
[TBL] [Abstract] [Full Text] [Related]
10. Human galectin-2: nuclear presence in vitro and its modulation by quiescence/stress factors.
Dvoránková B; Lacina L; Smetana K; Lensch M; Manning JC; André S; Gabius HJ
Histol Histopathol; 2008 Feb; 23(2):167-78. PubMed ID: 17999373
[TBL] [Abstract] [Full Text] [Related]
